Abstract
Myeloid differentiation (MyD) primary response and growth arrest DNA damage (Gadd) genes comprise a set of overlapping genes, including known (IRF-1, EGR-1, Jun) and novel (MyD88, Gadd45α, MyD118/Gadd45β, GADD45γ, MyD116/ Gadd34) genes, that have been cloned by virtue of being co-ordinately induced upon the onset of terminal myeloid differentiation and following exposure of cells to stress stimuli. In recent years it has become evident that MyD/Gadd play a role in blood cell development, where they function as positive regulators of terminal differentiation, lineage-specific blood cell development and control of blood cell homeostasis, including growth inhibition and apoptosis. MyD/Gadd are also involved in inflammatory responses to invading micro-organisms, and response to environmental stress and physiological stress, such as hypoxia, which results in ischemic tissue damage. An intricate network of interactions among MyD/GADD genes and gene products appears to control their diverse functions. Deregulated growth, increased cell survival, compromised differentiation and deficiencies in DNA repair are hallmarks of malignancy and its progression. Thus, the role MyD/Gadd play in negative growth control, including cell cycle arrest and apoptosis, and in DNA repair, make them attractive molecular targets for tumor suppression. The role MyD/Gadd play in innate immunity and host response to hypoxia also make these genes and gene products attractive molecular targets to treat immunity and inflammation disorders, such as septic shock and ischemic tissue damage.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Impacts of Early Life Stress on the Methylome and Transcriptome of Atlantic Salmon
Scientific Reports Open Access 10 July 2017
-
Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells
Scientific Reports Open Access 07 October 2016
-
Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis
Retrovirology Open Access 15 March 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Lord KA, Hoffman-Liebermann B, Liebermann DA . Complexity of the immediate early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1, Jun-B and histone variants Oncogene 1990 5: 387–396
Abdollahi A, Lord KA, Hoffman-Liebermann B, Liebermann DA . Interferon regulatory factor-1 is a myeloid differentiation primary response gene induced by IL6 and leukemia inhibitory factor: role in growth inhibition Cell Growth Diff 1991 2: 401–407
Lord KA, Abdollahi A, Hoffman-Liebermann B, Liebermann DA . Dissection of the immediate early response of myeloid leukemia cells to terminal differentiation and growth inhibitory stimuli Cell Growth Diff 1990 1: 637–645
Nguyen H, Hoffman-Liebermann B, Liebermann DA . The zinc finger transcription factor EGR-1 is essential for and restricts differentiation along the macrophage lineage Cell 1993 72: 197–209
Abdollahi A, Lord KA, Hoffman-Liebermann B, Liebermann DA . Sequence and expression of a cDNA encoding MyD118: a novel myeloid differentiation primary response gene induced by multiple cytokines Oncogene 1991 6: 165–167
Lord KA, Hoffman-Liebermann B, Liebermann DA . Sequence of MyD116 cDNA: a novel myeloid differentiation primary response gene induced by IL6 Nucleic Acids Res 1990 18: 2823
Lord KA, Hoffman-Liebermann B, Liebermann D . Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6 Oncogene 1990 5: 1095–1097
Fornace AJ, Jackman J, Hollander MC, Hoffman-Liebermann B, Liebermann DA . Genotoxic-stress-response genes and growth-arrest genes: gadd, MyD, and other genes induced by treatments eliciting growth arrest Ann NY Acad Sci 1992 663: 139–154
Fornace AJ Jr . Mammalian genes induced by radiation; activation of genes associated with growth control Annu Rev Genet 1992 26: 507–526
Zhan Q, Lord KA, Alamo I Jr, Hollander MC, Carrier F, Ron D, Kohn KW, Hoffman B, Liebermann DA, Fornace AJ Jr . The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth Mol Cell Biol 1994 14: 2361–2371
Beadling C, Johnson KW, Smith KA . Isolation of interleukin 2-induced immediate-early genes Proc Natl Acad Sci USA 1993 90: 2719–2723
Zhang W, Bae I, Krishnaraju K, Azam N, Fan W, Smith K, Hoffman B, Liebermann DA . CR6: A third member in the MyD118 and Gadd 45 gene family which functions in negative growth control Oncogene 1999 18: 4899–4907
Zhang W, Hoffman B, Liebermann DA . Ectopic expression of MyD118/Gadd45/CR6 (Gadd45beta/alpha/gamma) sensitizes neoplastic cells to genotoxic stress-induced apoptosis Int J Oncol 2001 18: 749–757
Zhang W . The MyD118/Gadd4/CR6 gene gamily in negative growth control Thesis. Temple University, July 2000
Takekawa M, Saito H . A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4/MAPKKK Cell 1998 95: 521–530
Fujita T, Kimura Y, Miyamoto M, Barsoumian EL, Taniguchi T . Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1 Nature 1989 337: 270–272
Harada H, Willison K, Sakakibara J, Miyamoto M, Fujita T, Taniguchi T . Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated Cell 1990 63: 303–312
Miyamoto M, Fugita T, Kimura Y, Maruyama M, Harada H, Sudo Y, Miyata T, Taniguchi T . Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements Cell 1988 54: 903–913
Squier MK, Sehnert AJ, Cohen JJ . Apoptosis in leukocytes J Leuk Biol 1995 57: 2–10
Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, Kundig TM, Amakawa R, Kishihara K, Wakeham A, Potter J, Furlonger CL, Narendran A, Suzuki H, Ohashi PS, Paige CJ, Taniguchi T, Mak TW . Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development Cell 1993 75: 83–97
Taniguchi T, Ogasawara K, Takaoka A, Tanaka N . IRF family of transcription factors as regulators of host defense Annu Rev Immunol 2001 19: 623–655
Janeway CA, Travers P, Walport M, Capra JD . Immunobiology: The Immune System in Health and Disease, 4th edn Garland: New York 1999
Nakanishi K . Innate and acquired activation pathways in T cells Nat Immunol 2001 2: 140–142
Taki S, Sato T, Ogasawara K, Fukuda T, Sato M, Hida S, Suzuki G, Mitsuyama M, Shin EH, Kojima S, Taniguchi T, Asano Y . Multistage regulation of Th1-type immune responses by the transcription factor IRF-1 Immunity 1997 6: 673–679
Lohoff M, Ferrick D, Mittrucker HW, Duncan GS, Bischof S, Rollinghoff M, Mak TW . Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo Immunity 1997 6: 681–689
Fantuzzi G, Reed D, Qi M, Scully S, Dinarello CA, Senaldi G . Role of interferon regulatory factor-1 in the regulation of IL-18 production and activity Eur J Immunol 2001 31: 369–375
Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M, Taniguchi T . Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage Nature 1996 382: 816–818
Nguyen H, Hiscott J . Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins Oncogene 1997 15: 1425–1435
Lallemand C, Bayat-Sarmadi M, Blanchard B, Tovey MG . Identification of a novel transcriptional regulatory element common to the p53 and interferon regulatory factor 1 genes J Biol Chem 1997 272: 29801–29809
Harada H, Kitgawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M, Taniguchi T . Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2 Science 1993 259: 971–974
Nozawa H, Oda E, Nakao K, Ishihara M, Ueda S, Yokochi T, Ogasawara K, Nakat-suru Y, Shimizu S, Ohira Y, Hioki K, Aizawa S, Ishikawa T, Katsuki M, Muto T, Taniguchi T, Tanaka N . Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53 Genes Dev 1999 13: 1240–1245
Willman CL, Sever CE, Palavicini MG, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF, Taniguchi T . Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia Science 1993 259: 968–971
Harada H, Kondo T, Ogawa S, Tamura T, Kitagawa M, Tanaka N, Lamphier MS, Hirai H, Taniguchi T . Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation Oncogene 1994 9: 3313–3320
Mayeda A, Helfman DM, Krainer AR . Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF Mol Cell Biol 1993 13: 2993–3001
Ogasawara S, Tamura G, Maesawa C, Suzuki Y, Ishida K, Satoh N, Uesugi N, Saito K, Satodate R . Common deleted region on the long arm of chro-mosome5 in esophageal carcinoma Gastroenterology 1996 110: 52–57
Tamura G, Ogasawara S, Nishizuka S, Sakata K, Maesawa C, Suzuki Y, Terashima M, Saito K, Satodate R . Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach Cancer Res 1996 56: 612–615
Nozawa H, Oda E, Ueda S, Tamura G, Maesawa C, Muto T, Taniguchi T, Tanaka N . Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer Int J Cancer 1998 77: 522–527
Kroger A, Ortmann D, Krohne TU, Mohr L, Blum HE, Hauser H, Geissler M . Growth suppression of the hepatocellular carcinoma cell line Hepa1–6 by an activatable interferon regulatory factor-1 in mice Cancer Res 2001 61: 2609–2617
Land H, Parada LF, Weinberg RA . Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes Nature 1983 304: 596–602
Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, Lamphier MS, Aizawa S, Mak TW, Taniguchi T . Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1 Cell 1994 77: 829–839
Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, Mat-suyama T, Mak TW, Taki S, Taniguchi T . An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes Nature 1995 376: 596–599
Sanceau J, Hiscott J, Delattre O, Wietzerbin J . IFN- induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7 Oncogene 2000 19: 3372–3383
Lee J, Hur J, Lee P, Kim JY, Cho N, Lee MS, Kim SY, Kim H, Suk K . Dual role of inflammatory stimuli in activation-induced cell death of mouse microglial cells: initiation of two separate apoptotic pathways via induction of interferon regulatory factor-1 and caspase-11 J Biol Chem 2001 11: 32956–32965
Tendler DS, Bao C, Wang T, Huang EL, Ratovitski EA, Pardoll DA, Lowenstein CJ . Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis Cancer Res 2001 61: 3682–3688
Suk K, Chang I, Kim YH, Kim S, Kim JY, Kim H, Lee MS . Interferon gamma (IFN gamma) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFN gamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways J Biol Chem 2001 276: 13153–13159
Suk K, Kim S, Kim YH, Kim KA, Chang I, Yagita H, Shong M, Lee MS . IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death J Immunol 2001 166: 4481–4489
Ashkenazi A, Dixit VM . Death receptors: signaling and modulation Science 1998 281: 1305–1308
Chow WA, Fang JJ, Yee JK . The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells J Immunol 2000 164: 3512–3518
Bos TJ, Bohmann D, Tsuchie H, Tjian R, Vogt PK . Genome, v-jun encodes a nuclear protein with enhancer binding properties of AP-1 Cell 1988 52: 705–712
Angel P, Allegretto EA, Okino ST, Hattori K, Boyle WJ, Hunter T, Karin M . Oncogene jun encodes a sequence-specific trans-activator similar to AP-1 Nature 1988 332: 166–171
Ryder K, Lau LF, Nathans D . A gene activated by growth factors is related to the oncogene v-jun Proc Natl Acad Sci USA 1988 85: 1487–1491
Ryder K, Lanahan A, Perez-Albuerne E, Nathans D . jun-D: a third member of the jun gene family Proc Natl Acad Sci USA 1989 86: 1500–1503
Ryder K, Lau LF, Nathans D . Protein, nucleotide A gene activated by growth factors is related to the oncogene v-jun Proc Natl Acad Sci USA 1988 85: 1487–1491
Liebermann D, Hoffman-Liebermann B . Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade Oncogene 1989 4: 583–592
Liebermann DA, Gregory B, Hoffman B . AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis Int J Oncol 1998 12: 685–700
Lord KA, Abdollahi A, Hoffman-Liebermann B, Liebermann DA . Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation Mol Cell Biol 1993 13: 841–851
Jochum W, Passegue E, Wagner EF . AP-1 in mouse development and tumorigenesis Oncogene 2001 20: 2401–2412
Passegue E, Jochum W, Schorpp-Kistner M, Mohle-Steinlein U, Wagner EF . Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage Cell 2001 104: 21–32
Smeyne RJ, Schilling K, Robertson L, Luk D, Oberdick J, Curran T, Morgan JI . fos-lacZ transgenic mice: mapping sites of gene induction in the central nervous system Neuron 1992 8: 13–23
Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan JI . Continuous c-fos expression precedes programmed cell death in vivo Nature 1993 363: 166–169
Roffler-Tarlov S, Brown JJ, Tarlov E, Stolarov J, Chapman DL, Alexiou M, Papaioannou VE . Programmed cell death in the absence of c-Fos and c-Jun Development 1996 122: 1–9
Estus S, Zaks WJ, Freeman RS, Gruda M, Bravo R, Johnson EM Jr . Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis J Cell Biol 1994 127: 1717–1727
Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M, Rubin LL . A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death Neuron 1995 14: 927–939
Le-Niculescu H, Bonfoco E, Kasuya Y, Claret FX, Green DR, Karin M . Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death Mol Cell Biol 1999 19: 751–763
Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME . Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 1995 270: 1326–1331
Bossy-Wetzel E, Bakiri L, Yaniv M . Induction of apoptosis by the transcription factor c-Jun EMBO J 1997 16: 1695–1709
Preston GA, Lyon TT, Yin Y, Lang JE, Solomon G, Annab L, Srinivasan DG, Alcorta DA, Barrett JC . Induction of apoptosis by c-Fos protein Mol Cell Biol 1996 16: 211–218
Herrlich P, Sachsenmaier C, Radler-Pohl A, Gebel S, Blattner C, Rahmsdorf HJ . The mammalian UV response mechanism of DNA damage induced gene expression Adv Enzym Regul 1994 34: 381–395
Holbrook NJ, Fornace AJ Jr . Response to adversity: molecular control of gene activation following genotoxic stress New Biologist 1991 3: 825–833
Karin M . The regulation of AP-1 activity by mitogen-activated protein kinases J Biol Chem 1995 270: 16483–16486
Su B, Karin M . Mitogen-activated protein kinase cascades and regulation of gene expression Curr Opin Immunol 1996 8: 402–411
Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN . Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis Nature 1996 380: 75–79
Shaulian E, Schreiber M, Piu F, Beeche M, Wagner EF, Karin M . The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest Cell 2000 103: 897–907
Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ . Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway Science 2000 288: 870–874
Kolbus A, Herr I, Schreiber M, Debatin KM, Wagner EF, Angel P . Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents Mol Cell Biol 2000 20: 575–582
Schreiber M, Baumann B, Cotten M, Angel P, Wagner EF . Fos is an essential component of the mammalian UV response EMBO J 1995 14: 5338–5349
Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, Green DR . DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1 Mol Cell 1998 1: 543–551
Faris M, Latinis KM, Kempiak SJ, Koretzky GA, Nel A . Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter Mol Cell Biol 1998 18: 5414–5424
Milbrandt J . A nerve growth factor-induced gene encodes a possible transcription regulatory factor Science 1987 238: 797–799
Sukhatme VP, Cao X, Chang LC, Tsai-Morris CW, Stamenkovich D, Ferreira PC, Cohen DR, Edwards SA, Shows TB, Curran T, Le Beau MM, Adamson ED . A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization Cell 1988 53: 37–43
Christy B, Nathans LF, Nathans D . A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with ‘zinc finger’ sequences Proc Natl Acad Sci USA 1988 85: 7857–7861
Nguyen H, Hoffman-Liebermann B, Liebermann DA . The zinc finger transcription factor EGR-1 is essential for and restricts differentiation along the macrophage lineage Cell 1993 72: 197–209
Krishnaraju K, Nguyen HQ, Liebermann DA, Hoffman B . The zinc finger transcription factor Egr-1 potentiates macrophage differentiation of hematopoietic cells Mol Cell Biol 1995 15: 5549–5507
Krishnaraju K, Liebermann DA, Hoffman B . Lineage specific regulation of hematopoiesis by Hox-B8 (Hox2.4): inhibition of granulocyte differentiation and potentiation of monocytic differentiation Blood 1997 90: 1840–1849
Krishnaraju K, Hoffman B, Liebermann DA . The zinc finger transcription factor Egr-1 activates macrophage differentiation in M1 myeloblastic leukemia cells Blood 1998 92: 1957–1966
Krishnaraju K, Hoffman B, Liebermann DA . Early growth response gene 1 stimulates development of hematopoietic progenitor cells along the macrophage lineage at the expense of the granulocyte and erythroid lineages Blood 2001 97: 1298–1305
Lee SL, Wang Y, Milbrandt J . Unimpaired macrophage differentiation and activation in mice lacking the zinc finger transcription factor NGFI-A (Egr1) Mol Cell Biol 1996 16: 45–66
Liu C, Rangnekar VM, Adamson E, Mercola D . Suppression of growth and transformation and induction of apoptosis by EGR-1 Cancer Gene Ther 1998 1: 3–28
Tourtellotte WG, Nagarajan R, Bartke A, Milbrandt J . Functional compensation by Egr4 in Egr1-dependent luteinizing hormone regulation and Leydig cell steroidogenesis Mol Cell Biol 2000 20: 5261–5268
Ahmed MM, Sells SF, Venkatasubbarao K, Fruitwala SM, Muthukkumar S, Harp C, Mohiuddin M, Rangnekar VM . Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1 J Biol Chem 1997 272: 33056–33061
Dziallo-Hatton R, Milbrandt J, Hockett RD Jr, Weaver CT . Differential expression of Fas ligand in Th1 and Th2 cells is regulated by early growth response gene and NF-AT family members J Immunol 2001 166: 4534–4542
Das A, Chendil D, Dey S, Mohiuddin M, Mohiuddin M, Milbrandt J, Rangnekar VM, Ahmed MM . Ionizing radiation down-regulates p53 protein in primary Egr-1-/- mouse embryonic fibroblast cells causing enhanced resistance to apoptosis J Biol Chem 2001 276: 3279–3286
Zhang W, Chen S . EGR-1, a UV-inducible gene in p53(-/-) mouse cells Exp Cell Res 2001 266: 21–30
Yan SF, Fujita T, Lu J, Okada K, Shan Zou Y, Mackman N, Pinsky DJ, Stern DM . Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress Nat Med 2000 6: 1355–1361
Laouar A, Collart FR, Chubb CB, Xie B, Huberman E . Interaction between alpha 5 beta 1 integrin and secreted fibronectin is involved in macrophage differentiation of human HL-60 myeloid leukemia cells J Immunol 1999 162: 407–414
Liu C, Yao J, Mercola D, Adamson E . The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251 J Biol Chem 2000 275: 20315–20323
Liu C, Yao J, de Belle I, Huang RP, Adamson E, Mercola D . The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1 J Biol Chem 1999 274: 4400–4411
Lord KA, Abdollahi A, Thomas SM, DeMarco M, Brugge JS, Hoffman-Liebermann B, Liebermann D . Leukemia inhibitory factor and interleukin-6 trigger the same immediate–early response including tyrosine phosphorylation upon induction of myeloid leukemia differentiation Mol Cell Biol 1991 11: 4371–4379
Kaisho T, Akira S . Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice Trends Immunol 2001 22: 78–83
Feinstein E, Kimchi A, Wallach D, Boldin M, Varfolomeev E . The death domain: a module shared by proteins with diverse cellular functions Trends Biochem Sci 1995 20: 342–344
Hardiman G, Rock FL, Balasubramanian S, Kastelein RA, Bazan JF . Molecular characterization and modular analysis of human MyD88 Oncogene 1996 13: 2467–2475
Hofmann K, Tschopp J . The death domain motif found in Fas (Apo-1) and TNF receptor is present in proteins involved in apoptosis and axonal guidance FEBS Lett 1995 371: 321–323
Hultmark D . Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family Biochem Biophys Res Commun 1994 199: 144–146
Mitcham JL, Parnet P, Bonnert TP, Garka KE, Gerhart MJ, Slack JL, Gayle MA, Dower SK, Sims JE . T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family J Biol Chem 1996 271: 5777–5783
Yamagata M, Merlie JP, Sanes JR . Interspecific comparisons reveal conserved features of the Drosophila Toll protein Gene Amst 1994 139: 223–228
Itoh N, Nagata S . A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen J Biol Chem 1993 268: 10932–10937
Tartaglia LA, Ayres TM, Wong GH, Goeddel DV . A novel domain within the 55 kDa TNF receptor signals cell death Cell 1993 74: 845–853
Hashimoto C, Hudson KL, Anderson V . The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein Cell 1988 52: 269–279
Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, Janeway CA Jr . MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways Mol Cell 1998 2: 253–258
Parnet P, Garka KE, Bonnert TP, Dower S, Sims JE . IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP J Biol Chem 1996 271: 3967–3970
Dinarello CA . Biologic basis for interleukin-1 in disease Blood 1996 87: 2095–2147
Barnes PJ, Karin M . Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases N Engl J Med 1997 336: 1066–1071
Baeuerle PA, Baltimore D . NF-kappa B: ten years after Cell 1996 87: 13–20
Baldwin AS Jr . The NF-kappa B and I kappa B proteins: new discoveries and insights Annu Rev Immunol 1996 14: 649–683
Ghosh S, May MJ, Kopp E . NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses Annu Rev Immunol 1998 16: 225–260
Karin M . The NF-kappa B activation pathway: its regulation and role in inflammation and cell survival Cancer J Sci Am 1998 (Suppl. 1): S92–S99
Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G . Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex J Biol Chem 1995 270: 13757–13765
Huang J, Gao X, Li S, Cao Z . Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein Proc Natl Acad Sci USA 1997 94: 12829–12832
Korherr C, Hofmeister R, Wesche H, Falk W . A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling Eur J lmmunol 1997 27: 262–267
Wesche H, Korherr C, Kracht M, Falk W, Resch K, Martin MU . The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases) J Biol Chem 1997 272: 7727–7731
Cao Z, Henzel WJ, Gao X . IRAK: a kinase associated with the interleukin-1 receptor Science 1996 271: 1128–1131
Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV . TRAF6 is a signal transducer for interleukin-1 Nature 1996 383: 443–446
Aizawa S, Nakano H, Ishida T, Horie R, Nagai M, Ito K, Yagita H, Okumura K, Inoue J, Watanabe T . Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation J Biol Chem 1997 272: 2042–2045
Duckett CS, Gedrich RW, Gilfillan MC, Thompson CB . Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2 Mol Cell Biol 1997 17: 1535–1542
Hsu H, Shu HB, Pan MG, Goeddel DV . TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways Cell 1996 84: 299–308
Ishida TK, Tojo T, Aoki T, Kobayashi N, Ohishi T, Watanabe T, Yamamoto T, Inoue J . TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling Proc Natl Acad Sci USA 1996 93: 9437–9442
Nakano H, Oshima H, Chung W, Williams-Abbott L, Ware CF, Yagita H, Okumirra K . TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor J Biol Chem 1996 271: 14661–14664
Rothe M, Sarma V, Dixit VM, Goeddel DV . TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 Science 1995 269: 424–427
Di Donato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M . A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB Nature 1997 388: 548–554
Malinin NL, Boldin MP, Kovalenko AV, Wallach D . MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1 Nature 1997 385: 540–544
Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A . IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation Science 1997 278: 860–866
Regnier CH, Song H, Gao X, Goeddel DV, Cao Z, Rothe M . Identification and characterization of an IkappaB kinase Cell 1997 90: 373–383
Song HY, Regnier CH, Kirschning CJ, Goeddel DV, Rothe M . Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2 Proc Natl Acad Sci USA 1997 94: 9792–9796
Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV . IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK Science 1997 278: 866–870
Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M . The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation Cell 1997 91: 243–252
Yanagisawa K, Takagi T, Tsukamoto T, Tetsuka T, Tominaga S . Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1 FEBS Lett 1993 318: 83–87
Lovenberg TW, Crowe PD, Liu C, Chalmers DT, Liu XJ, Liaw C, Clevenger W, Oltersdorf T, De Souza EB, Maki RA . Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2) 1996, J Neuroimmunol 1996 70: 113–122
Parnet P, Garka KE, Bonnert TP, Dower S, Sims JE . IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP J Biol Chem 1996 271: 3967–3970
Medzhitov R, Preston-Hurlburt P, Janeway CA Jr . A human homologue of the Drosophila Toll protein signals activation of adaptive immunity Nature 1997 388: 394–397
Parker JE, Coleman MJ, Szabo V, Frost LN, Schmidt R, van der Biezen EA, Moores T, Dean C, Daniels MJ, Jones JD . The Arabidopsis downy mildew resistance gene RPP5 shares similarity to the toll and interleukin-1 receptors with N and L6 Plant Cell 1997 9: 879–894
Eldon E, Kooyer S, D'Evelyn D, Duman M, Lawinger P, Botas J, Bellen H . The Drosophila 18 wheeler is required for morphogenesis and has striking similarities to Toll Development 1994 120: 885–899
Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoflmann JA . The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults Cell 1996 86: 973–983
Wasserman SA . A conserved signal transduction pathway regulating the activity of the rel-like proteins dorsal and NF-kappa B Mol Biol Cell 1993 4: 767–771
Belvin MP, Anderson KV . A conserved signaling pathway: the Drosophila toll-dorsal pathway Annu Rev Cell Dev Biol 1996 12: 393–416
Norris JL, Manley JL . Functional interactions between the pelle kinase, Toll receptor, and tube suggest a mechanism for activation of dorsal Genes Dev 1996 10: 862–872
Letsou A, Alexander S, Wassermar SA . Domain mapping of tube, a protein essential for dorsoventral patterning of the Drosophila embryo EMBO J 1993 12: 3449–3458
Shelton CA, Wasserman SA . pelle encodes a protein kinase required to establish dorsoventral polarity in the Drosophila embryo Cell 1993 7: 515–525
Galindo RL, Edwards DN, Gillespie SK, Wasserman SA . Interaction of the pelle kinase with the membrane-associated protein tube is required for transduction of the dorsoventral signal in Drosophila embryos Development 1995 121: 209–218
Grosshans J, Bergmann A, Haffter P, Nusslein-Volhard C . Activation of the kinase Pelle by Tube in the dorsoventral signal transduction pathway of Drosophila embryo Nature 1994 372: 563–566
Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer JL, Di Marco F, French L, Tschopp J . MyD88, an adapter protein involved in interleukin-1 signaling J Biol Chem 1998 273: 12203–12209
Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao ZI . MyD88: an adapter that recruits IRAK to the IL-1 receptor complex Immunity 1997 7: 837–847
Muzio M, Ni J, Feng P, Dixit VM . IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling Science 1997 278: 1612–1651
Aderem A, Ulevitch RJ . Toll-like receptors in the induction of the innate immune response Nature 2001 406: 782–787
Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, Janeway CA Jr . MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways Mol Cell 1998 2: 253–258
Kawai T, Adachi O, Ogawa T, Takeda K, Akira S . Unresponsiveness of MyD88-deficient mice to endotoxin Immunity 1999 11: 115–122
Xu Y, Tao X, Shen B, Horng T, Medzhitov R, Manley JL, Tong L . Structural basis for signal transduction by the Toll/interleukin-1 receptor domains Nature 2000 408: 111–115
Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S . Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function Immunity 1998 9: 143–150
Hsu H, Xiong J, Goeddel DV . The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B Cell 1995 81: 495–504
Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV . TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex Immunity 1996 4: 387–396
Boldin MP, Goncharov TM, Goltsev YV, Wallach D . Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death Cell 1996 85: 803–815
Grimm S, Stanger BZ, Leder P . RIP and FADD: two ‘death domain’-containing proteins can induce apoptosis by convergent, but dissociable, pathways Proc Natl Acad Sci USA 1996 93: 10923–10927
Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM . FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 1996 85: 817–827
Jaunin F, Burns K, Tschopp J, Martin TE, Fakan S . Ultrastructural distribution of the death-domain-containing MyD88 protein in HeLa cells Exp Cell Res 1998 243: 67–75
Dupraz P, Cottet S, Hamburger F, Dolci W, Felley-Bosco E, Thorens B . Dominant negative MyD88 proteins inhibit interleukin-1beta/interferon-gamma-mediated induction of nuclear factor kappa B-dependent nitrite production and apoptosis in beta cells J Biol Chem 2000 275: 37672–37678
Schmidt A, Caron E, Hall A . Lipopolysaccharide-induced activation of beta2-integrin function in macrophages requires Irak kinase activity, p38 mitogen-activated protein kinase, and the Rap1 GTPase Mol Cell Biol 2001 21: 438–448
Su ZZ, Shi Y, Fisher PB . Subtraction hybridization identifies a transformation progression-associated gene PEG-3 with sequence homology to a growth arrest and DNA damage-inducible gene Proc Natl Acad Sci USA 1997 94: 9125–9130
McGeoch DJ, Barnett BC . Neurovirulence factor Nature 1991 353: 609
Chou J, Roizman B . Herpes simplex virus 1 gamma(1)34.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage Proc Natl Acad Sci USA 1994 91: 5247–5251
He B, Chou J, Liebermann DA, Hoffman B, Roizman B, Marjorie B . The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1)34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells J Virol 1996 70: 84–90
He B, Gross M, Roizman B . The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase Proc Natl Acad Sci USA 1997 94: 843–848
Sussman MD, Lu Z, Kutish G, Afonso CL, Roberts P, Rock DL . Identification of an African swine fever virus gene with similarity to a myeloid differentiation primary response gene and a neurovirulence-associated gene of herpes simplex virus J Virol 1992 66: 5586–5591
Vydelingum S, Baylis SA, Bristow C, Smith GL, Dixon LK . Duplicated genes within the variable right end of the genome of a pathogenic isolate of African swine fever virus J Gen Virol 1993 74: 2125–2130
Dixon LK, Twigg SR, Baylis SA, Vydelingum S, Bristow C, Hammond JM, Smith GL . Nucleotide sequence of a 55 kbp region from the right end of the genome of a pathogenic African swine fever virus isolate (Malawi LIL20/1) J Gen Virol 1994 75: 1655–1684
Zsak L, Lu Z, Kutish GF, Neilan JG, Rock DL . An African swine fever virus virulence-associated gene NL-S with similarity to the herpes simplex virus ICP34.5 gene J Virol 1996 70: 8865–8871
Hollander MC, Sheikh MS, Yu K, Zhan Q, Iglesias M, Woodworth C, Fornace AJ Jr . Activation of Gadd34 by diverse apoptotic signals and suppression of its growth inhibitory effects by apoptotic inhibitors Int J Cancer 2001 96: 22–31
Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC, Fornace AJ Jr . An informatics approach identifying markers of chemosensitivity in human cancer cell lines Cancer Res 2000 60: 6101–6110
Novoa I, Zeng H, Harding HP, Ron D . Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha J Cell Biol 2001 153: 1011–1022
Adler HT, Chinery R, Wu DY, Kussick SJ, Payne JM, Fornace AJ Jr, Tkachuk DC . Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins Mol Cell Biol 1999 19: 7050–7060
Brown SM, MacLean AR, McKie EA, Harland JJ . The herpes simplex virus virulence factor ICP34.5 and the cellular protein MyD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34 J Virol 1997 71: 9442–9449
Hasegawa T, Yagi A, Isobe K . Interaction between GADD34 and kinesin superfamily, KIF3A Biochem Biophys Res Commun 2000 267: 593–596
Hasegawa T, Xiao H, Hamajima F, Isobe K . Interaction between DNA-damage protein GADD34 and a new member of the Hsp40 family of heat shock proteins that is induced by a DNA-damaging reagent Biochem J 2000 352: 795–780
Hasegawa T, Isobe K . Evidence for the interaction between Translin and GADD34 in mammalian cells Biochim Biophys Acta 1999 1428: 161–168
Hasegawa T, Xiao H, Isobe K . Cloning of a GADD34-like gene that interacts with the zinc-finger transcription factor which binds to the p21(WAF) promoter Biochem Biophys Res Commun 1999 256: 249–254
Papathanasiou MA, Kerr NC, Robbins JH, McBride OW, Alamo I Jr, Barrett SF, Hickson ID, Fornace AJ Jr . Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents Mol Cell Biol 1989 10: 4196–4203
Fornace AJ Jr, Nebert DW, Hollander MC, Luethy JD, Papathanasiou M, Fargnoli J, Holbrook NJ . Induction by ionizing radiation of the gadd45 gene in cultured human cells: lack of mediation by protein kinase C Mol Cell Biol 1991 11: 1009–1016
Vairapandi M, Balliet AG, Hoffman B, Liebermann DA . The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1 Oncogene 1996 12: 2579–2594
Liebermann DA, Hoffman B . MyD genes in negative growth control Oncogene Rev 1998 17: 3319–3330
Selvakumaran M, Lin HK, Tjin Tham Sjin R, Reed J, Liebermann D, Hoffman B . The novel primary response gene MyD118 and the proto-oncogenes myb, myc and bcl-2 modulate transforming growth factor b1-induced apoptosis of myeloid leukemia cells Mol Cell Biol 1994 14: 2352–2360
Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B, Liebermann D . Immediate early up-regulation of bax expression by p53 but not TGFb1: a paradigm for distinct apoptotic pathways Oncogene 1994 9: 1791–1798
Guillouf C, Grana X, Selvakumaran M, Hoffman B, Giordano A, Liebermann DA . Dissection of the genetic programs of p53 G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest Blood 1995 85: 2691–2698
Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr . A mammalian cell cycle checkpoint utilizing p53 and gadd45 is defective in Ataxia-telangiectasia Cell 1992 71: 587–597
Wang X, Gorospe M, Holbrook NJ . Gadd45 is not required for activation of c-Jun N-terminal kinase or p38 during acute stress J Biol Chem 1999 274: 29599–29602
Shaulian E, Karin M . Stress-induced JNK activation is independent of Gadd45 induction J Biol Chem 1999 274: 29595–29598
Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez-Salguero PM, Morgan WF, Deng CX, Fornace AJ Jr . Genomic instability in Gadd45a-deficient mice Nat Genet 1999 23: 176–184
Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM, Fornace AJ Jr . Protein interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen Science 1994 266: 1376–1380
Smith ML, Ford JM, Hollander MC, Bortnick RA, Amundson SA, Seo YR, Deng CX, Hanawalt PC, Fornace AJ Jr . p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes Mol Cell Biol 2000 20: 3705–3714
BVairapandi M, Azam N, Balliet AG, Hoffman B, Liebermann DA . Characterization of MyD118, Gadd45, and PCNA interacting domains: PCNA impedes MyD/Gadd mediated negative growth control J Biol Chem 2000 275: 16810–16819
Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD, Haber DA . Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1 Cell 1999 97: 575–586
Azam N, Vairapandi M, Zhang W, Hoffman B, Liebermann DA . Interaction of CR6 (GADD45{gamma}) with proliferating cell nuclear antigen (PCNA) impedes negative growth control J Biol Chem 2000 26: 2766–2774
Smith ML, Kontny HU, Zhan Q, Sreenath A, O'Connor PM, Fornace AJ Jr . Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to UV-irradiation or cisplatin Oncogene 1996 13: 2255–2263
Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace AJ Jr, Harris CC . GADD45 induction of a G2/M cell cycle checkpoint Proc Natl Acad Sci USA 1999 96: 3706–3711
Vairapandi M, Baliet AG, Hoffman B, Liebermann DA . GADD45 proteins are cdc2/cyclinB1 kinase inhibitors with a role in G2/M cell cycle arrest (Submitted)
Li S, Ting NS, Zheng L, Chen PL, Ziv Y, Shiloh Y, Lee EY, Lee WH . Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response Nature 2000 406: 210–215
Kojima S, Mayumi-Matsuda K, Suzuki H, Sakata T . Molecular cloning of rat GADD45gamma, gene induction and its role during neuronal cell death FEBS Lett 1999 446: 313–317
Kovalsky O, Lung FD, Roller PP, Fornace J . Oligomerization of human Gadd45a protein J Biol Chem 2001 176: 39330–39339
Sancar A . Mechanisms of DNA excision repair Science 1994 266: 1954–1956
Jonsson ZO, Hubsche U . Proliferating cell nuclear antigen: more than a clamp for DNA polymerases BioEssays 1997 19: 967–975
Kelman Z, Hurwitz J . Protein–PCNA interactions: a DNA-scanning mechanism? Trends Biochem Sci 1998 23: 236–238
Cheung KJ Jr, Mitchell D, Lin P, Li G . The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA Cancer Res 2001 61: 4974–4977
Carrier F, Georgel PT, Pourquier P, Blake M, Kontny HU, Antinore MJ, Gariboldi M, Myers TG, Weinstein JN, Pommier Y, Fornace AJ Jr . Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin Mol Cell Biol 1999 19: 1673–1685
Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC, Fornace AJ Jr . Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45 Oncogene 1999 18: 2892–2900
Jin S, Antinore MJ, Lung FD, Dong X, Zhao H, Fan F, Colchagie AB, Blanck P, Roller PP, Fornace AJ Jr, Zhan Q . The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression J Biol Chem 2000 275: 16602–16608
Yang Q, Manicone A, Coursen JD, Linke SP, Nagashima M, Forgues M, Wang XW . Identification of a functional domain in a Gadd45-mediated G2/M checkpoint J Biol Chem 2000 275: 36892–36898
O'Connor PM . Mammalian G1 and G2 phase checkpoints Cancer Surv 1997 29: 151–182
Elledge SJ . Cell cycle checkpoints: preventing an identity crisis Science 1996 274: 1664–1672
Zhang H, Xiong Y, Beach D . Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes Mol Biol Cell 1993 4: 897–906
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D . p21 is a universal inhibitor of cyclin kinases Nature 1993 366: 701–704
Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ . The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 Cell 1993 75: 805–816
El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . WAF1, a potential mediator of p53 tumor suppression Cell 1993 75: 817–825
Deng C, Zhang P, Harper JW, Elledge SJ, Leder P . Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control Cell 1995 82: 675–684
Chan TA, Hwang PM, Hermeking H, Kinzler KW, Vogelstein B . Cooperative effects of genes controlling the G(2)/M checkpoint Genes Dev 2000 14: 1584–1588
Yang J, Zhu H, Murphy TL, Ouyang W, Murphy KM . IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production Nat Immunol 2001 2: 157–164
Lu B, Yu H, Chow C, Li B, Zheng W, Davis RJ, Flavell RA . GADD45gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells Immunity 2001 14: 583–590
Hanahan D, Weinberg RA . The hallmarks of cancer Cell 2000 100: 57–70
Sawyers CL, Denny CT, Witte ON . Leukemia and the disruption of normal hematopoiesis Cell 1991 64: 337–350
Stanbridge EJ, Nowell PC . Origins of human cancer revisited Cell 1990 63: 867–874
Acknowledgements
I would like to thank Dr Arthur Balliet and Dr Arshad Amanullah for critical reading of the review.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liebermann, D., Hoffman, B. Myeloid Differentiation (MyD)/Growth Arrest DNA Damage (GADD) genes in tumor suppression, immunity and inflammation. Leukemia 16, 527–541 (2002). https://doi.org/10.1038/sj.leu.2402477
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402477
Keywords
This article is cited by
-
PET/CT-based deep learning grading signature to optimize surgical decisions for clinical stage I invasive lung adenocarcinoma and biologic basis under its prediction: a multicenter study
European Journal of Nuclear Medicine and Molecular Imaging (2024)
-
Knockout of the RAS endoprotease RCE1 accelerates myeloid leukemia by downregulating GADD45b
Leukemia (2021)
-
Impacts of Early Life Stress on the Methylome and Transcriptome of Atlantic Salmon
Scientific Reports (2017)
-
Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis
Retrovirology (2016)
-
Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells
Scientific Reports (2016)